These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3868 related articles for article (PubMed ID: 6895773)

  • 1. Antitumor effect of tuftsin.
    Nishioka K; Babcock GF; Phillips JH; Noyes RD
    Mol Cell Biochem; 1981 Dec; 41():13-8. PubMed ID: 6895773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
    Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
    Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuftsin: a naturally occurring immunopotentiating factor. I. In vitro enhancement of murine natural cell-mediated cytotoxicity.
    Phillips JH; Babcock GF; Nishioka K
    J Immunol; 1981 Mar; 126(3):915-21. PubMed ID: 6893996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo immunopharmacological properties of tuftsin (Thr-Lys-Pro-Arg) and some analogues.
    Florentin I; Chung V; Martinez J; Maral J; Le Garrec Y; Mathé G
    Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):73-80. PubMed ID: 2423822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuftsin: an immunomodulating peptide hormone and its clinical potential as a natural biological response modifier.
    Nishioka K; Amoscato AA; Babcock GF; Banks RA; Phillips JH
    Cancer Invest; 1984; 2(1):39-49. PubMed ID: 6322938
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo and in vitro antitumor activities of tuftsin.
    Nishioka K; Babcock GF; Phillips JH; Banks RA; Amoscato AA
    Ann N Y Acad Sci; 1983; 419():234-41. PubMed ID: 6324636
    [No Abstract]   [Full Text] [Related]  

  • 7. Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells.
    Tzehoval E; Segal S; Stabinsky Y; Fridkin M; Spirer Z; Feldman M
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3400-4. PubMed ID: 277940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by tuftsin of Rauscher virus leukemia development in mice.
    Knyszynski A; Gottlieb P; Fridkin M
    J Natl Cancer Inst; 1983 Jul; 71(1):87-90. PubMed ID: 6575215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuftsin: its chemistry, biology, and clinical potential.
    Fridkin M; Najjar VA
    Crit Rev Biochem Mol Biol; 1989; 24(1):1-40. PubMed ID: 2667894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage activation by tuftsin and muramyl-dipeptide.
    Bruley-Rosset M; Florentin I; Mathè G
    Mol Cell Biochem; 1981 Dec; 41():113-8. PubMed ID: 6895772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuftsin, a natural activator of phagocyte cells: an overview.
    Najjar VA
    Ann N Y Acad Sci; 1983; 419():1-11. PubMed ID: 6370072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro induction of human granulocyte cytotoxicity by tuftsin.
    Nishioka K
    Gan; 1979 Dec; 70(6):845-6. PubMed ID: 583412
    [No Abstract]   [Full Text] [Related]  

  • 13. The antineoplastic effects of tuftsin and tuftsinyltuftsin on B16/5B melanoma and L1210 cells.
    Najjar VA; Linehan L; Konopińska D
    Ann N Y Acad Sci; 1983; 419():261-7. PubMed ID: 6324637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo immunomodulating properties of two synthetic agents: azimexon and tuftsin.
    Florentin I; Schulz J; Bruley-Rosset M; Kiger N; Martinez J; Mathé G
    Recent Results Cancer Res; 1980; 75():153-61. PubMed ID: 6894500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostimulation by a partially modified retro-inverso-tuftsin analogue containing Thr1 psi[NHCO](R,S)Lys2 modification.
    Verdini AS; Silvestri S; Becherucci C; Longobardi MG; Parente L; Peppoloni S; Perretti M; Pileri P; Pinori M; Viscomi GC
    J Med Chem; 1991 Dec; 34(12):3372-9. PubMed ID: 1766001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of the neurochemical mechanisms of the psychotropic action of tuftsin and its analogs].
    Val'dman AV; Bondarenko NA; Kamysheva VA; Kozlovskaia MM; Kalikhevich VN
    Biull Eksp Biol Med; 1982 Apr; 93(4):57-60. PubMed ID: 6123353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal activity of tuftsin.
    Martinez J; Winternitz F
    Mol Cell Biochem; 1981 Dec; 41():123-36. PubMed ID: 6799777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polytuftsin: a potential precursor for slow release of the phagocytosis stimulating peptide tuftsin.
    Surkis R; Rubinraut S; Dagan S; Tzehoval E; Fridkin M; Ben Yoseph R; Catane R
    Int J Biochem; 1990; 22(2):193-5. PubMed ID: 2332102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted Drug Delivery Using Tuftsin-bearing Liposomes: Implications in the Treatment of Infectious Diseases and Tumors.
    Khan MA
    Curr Drug Targets; 2021; 22(7):770-778. PubMed ID: 33243117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuftsin-induced enhancement of murine and human natural cell-mediated cytotoxicity.
    Phillips JH; Nishioka K; Babcock GF
    Ann N Y Acad Sci; 1983; 419():192-204. PubMed ID: 6585168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 194.